Kathryn M. Hart

Kathryn M. Hart

Auto-generated profile, based on publicly available information

Kathryn M. Hart

Department of Chemistry Williams College Williamstown Massachusetts USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
GBGregory R. Bowman
Gregory R. Bowman
EBEric R. Bolin
Eric R. Bolin
KHKathryn M. Hart
Kathryn M. Hart
BMBrendan C. Maguire
Brendan C. Maguire
SMSusan Marqusee
Susan Marqusee
Significance: Rational drug design efforts typically focus on identifying inhibitors that bind to protein active sites. Pockets that are not present in crystallographic structures yet can exert allosteric (i.e., long-range) control over distant active sites present an exciting alternative. However, identifying these hidden allosteric sites is extremely challenging because one usually has to simultaneously find a small molecule that binds to and stabilizes the open conformation of the pocket. Here, we present a means of combining advances in computer modeling—using Markov state models to capture long timescale dynamics—with biophysical experiments to identify hidden allosteric sites without requiring the simultaneous discovery of drug-like compounds that bind them. Using this technology, we discover multiple hidden allosteric sites in a single protein.

6 October 2016 in Nature Communications
Verified
Journal Article
Open access
PDF file
KHKathryn M. Hart
Kathryn M. Hart
CHChris M. W. Ho
Chris M. W. Ho
SDSupratik Dutta
Supratik Dutta
MGMichael L. Gross
Michael L. Gross
GBGregory R. Bowman
Gregory R. Bowman
TEM β-lactamase confers bacteria with resistance to many antibiotics and rapidly evolves activity against new drugs. However, functional changes are not easily explained by differences in crystal structures. We employ Markov state models to identify hidden conformations and explore their role in determining TEM’s specificity. We integrate these models with existing drug-design tools to create a new technique, called Boltzmann docking, which better predicts TEM specificity by accounting for conformational heterogeneity. Using our MSMs, we identify hidden states whose populations correlate with activity against cefotaxime. To experimentally detect our predicted hidden states, we use rapid mass spectrometric footprinting and confirm our models’ prediction that increased cefotaxime activity correlates with reduced Ω-loop flexibility. Finally, we design novel variants to stabilize the hidden cefotaximase states, and find their populations predict activity against cefotaxime in vitro and in vivo. Therefore, we expect this framework to have numerous applications in drug and protein design.

11 November 2014 in PLOS Biology
Verified
Journal Article
Open access
PDF file
KHKathryn M. Hart
Kathryn M. Hart
MHMichael J. Harms
Michael J. Harms
BSBryan H. Schmidt
Bryan H. Schmidt
CECarolyn Elya
Carolyn Elya
JTJoseph W. Thornton
Joseph W. Thornton
SMSusan Marqusee
Susan Marqusee
Proteins from thermophiles are generally more thermostable than their mesophilic homologs, but little is known about the evolutionary process driving these differences. Here we attempt to understand how the diverse thermostabilities of bacterial ribonuclease H1 (RNH) proteins evolved. RNH proteins from Thermus thermophilus (ttRNH) and Escherichia coli (ecRNH) share similar structures but differ in melting temperature (Tm) by 20°C. ttRNH's greater stability is caused in part by the presence of residual structure in the unfolded state, which results in a low heat capacity of unfolding (ΔCp) relative to ecRNH. We first characterized RNH proteins from a variety of extant bacteria and found that Tm correlates with the species' growth temperatures, consistent with environmental selection for stability. We then used ancestral sequence reconstruction to statistically infer evolutionary intermediates along lineages leading to ecRNH and ttRNH from their common ancestor, which existed approximately 3 billion years ago. Finally, we synthesized and experimentally characterized these intermediates. The shared ancestor has a melting temperature between those of ttRNH and ecRNH; the Tms of intermediate ancestors along the ttRNH lineage increased gradually over time, while the ecRNH lineage exhibited an abrupt drop in Tm followed by relatively little change. To determine whether the underlying mechanisms for thermostability correlate with the changes in Tm, we measured the thermodynamic basis for stabilization—ΔCp and other thermodynamic parameters—for each of the ancestors. We observed that, while the Tm changes smoothly, the mechanistic basis for stability fluctuates over evolutionary time. Thus, even while overall stability appears to be strongly driven by selection, the proteins explored a wide variety of mechanisms of stabilization, a phenomenon we call “thermodynamic system drift.” This suggests that even on lineages with strong selection to increase stability, proteins have wide latitude to explore sequence space, generating biophysical diversity and potentially opening new evolutionary pathways. The biophysical properties of proteins must adjust to accommodate environmental temperatures because of the narrow range over which any given protein sequence can remain folded and functional. We compared the evolution of homologous bacterial enzymes (ribonucleases H1) from two lineages: one from Escherichia coli, which live at moderate temperatures, the other from Thermus thermophilus, which live at extremely high temperatures. Our aim was to investigate how these structurally homologous proteins can have such different thermostabilities, unfolding at temperatures that are 20°C apart. We used bioinformatics to reconstruct the sequences of ancestral proteins along each lineage, synthesized the proteins in the lab, and experimentally traced the evolution of ribonuclease H1 stability. While thermostability appears to have been strongly shaped by selection, the biophysical mechanisms used to tune protein stability appear to have varied throughout evolutionary history; this suggests that proteins have wide latitude to explore different mechanisms of stabilization, generating biophysical diversity and opening up new evolutionary pathways.

25 February 2006 in Journal of Combinatorial Chemistry
Verified
Journal Article
Closed access
MPMargot G. Paulick
Margot G. Paulick
KHKathryn M. Hart
Kathryn M. Hart
KBKristin M. Brinner
Kristin M. Brinner
MTMeiliana Tjandra
Meiliana Tjandra
DCDeborah H. Charych
Deborah H. Charych
RZRonald N. Zuckermann
Ronald N. Zuckermann

1 June 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KHKathryn M Hart
Kathryn M Hart
KMKatelyn E Moeder
Katelyn E Moeder
CHChris M W Ho
Chris M W Ho
MZMaxwell I Zimmerman
Maxwell I Zimmerman
TFThomas E Frederick
Thomas E Frederick
GBGregory R Bowman
Gregory R Bowman
Allosteric drugs, which bind to proteins in regions other than their main ligand-binding or active sites, make it possible to target proteins considered “undruggable” and to develop new therapies that circumvent existing resistance. Despite growing interest in allosteric drug discovery, rational design is limited by a lack of sufficient structural information about alternative binding sites in proteins. Previously, we used Markov State Models (MSMs) to identify such “cryptic pockets,” and here we describe a method for identifying compounds that bind in these cryptic pockets and modulate enzyme activity. Experimental tests validate our approach by revealing both an inhibitor and two activators of TEM β-lactamase (TEM). To identify hits, a library of compounds is first virtually screened against either the crystal structure of a known cryptic pocket or an ensemble of structures containing the same cryptic pocket that is extracted from an MSM. Hit compounds are then screened experimentally and characterized kinetically in individual assays. We identify three hits, one inhibitor and two activators, demonstrating that screening for binding to allosteric sites can result in both positive and negative modulation. The hit compounds have modest effects on TEM activity, but all have higher affinities than previously identified inhibitors, which bind the same cryptic pocket but were found, by chance, via a computational screen targeting the active site. Site-directed mutagenesis of key contact residues predicted by the docking models is used to confirm that the compounds bind in the cryptic pocket as intended. Because hit compounds are identified from docking against both the crystal structure and structures from the MSM, this platform should prove suitable for many proteins, particularly targets whose crystal structures lack obvious druggable pockets, and for identifying both inhibitory and activating small-molecule modulators.

31 October 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SLShion A. Lim
Shion A. Lim
KHKathryn M. Hart
Kathryn M. Hart
MHMichael J. Harms
Michael J. Harms
SMSusan Marqusee
Susan Marqusee
Significance: Because protein folding is crucial to proper cellular function, there must be evolutionary pressures on how a protein achieves and maintains its folded structure. The outcome of these pressures on a folding pathway should be reflected in trends and patterns over a protein’s evolutionary history. To understand how folding pathways evolve, we characterized how reconstructed ancestral proteins of the ribonuclease H family fold. The deepest ancestors fold and unfold faster than their modern descendants, and kinetic stability evolved along both mesophilic and thermophilic lineages. This trend is possible because of a conserved partially folded intermediate state, which uncouples thermodynamic and kinetic stability to allow each parameter to evolve independently.